Diabetes News

SAN DIEGO — In this video exclusive, Richard Pratley, MD, discusses diabetes remission and the need for more information and clinical trials to understand the impact of remission on long-term outcomes.

Among people with diabetes, higher loneliness scores, but not isolation scores, were associated with greater risk for CVD, suggesting the quality but not quantity of relationships can impact disease risk, researchers reported.

SAN DIEGO — Adults with overweight or obesity lost up to 18.7% of their body weight at 46 weeks with a glucagon/GLP-1 dual agonist, according to a speaker.

SAN DIEGO — In this video exclusive, three experts on type 1 diabetes in pregnancy offer tips for off-label use of automated insulin delivery systems for improving glycemic targets and quality of life during pregnancy.

An intervention based on a plant-predominant diet and education helped patients with type 2 diabetes achieve remission, a study published in the American Journal of Lifestyle Medicine showed.

The FDA approved an allogenic pancreatic islet cellular therapy for adults with type 1 diabetes who struggled to achieve their target HbA1c due to repeated episodes of severe hypoglycemia, according to an agency press release.

Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with Tessa Cushman, RDN, about addressing health inequities for people living with diabetes who identify as LGBTQ+.

Researchers observed no increased risk for new-onset diabetes among IMPROVE-IT participants assigned to ezetimibe plus statin therapy vs. statin monotherapy, according to a research letter.

The use of continuous glucose monitoring and hybrid closed-loop insulin delivery systems increased among youths with type 1 diabetes from 2016-2017 to 2020-2021 and may have helped reduce HbA1c, according to a brief report.

SAN DIEGO — In this video exclusive, Dana Lewis, a founder of OpenAPS, discusses how open-source, automated, closed-loop insulin delivery systems can benefit people living with type 1 diabetes.